Presented:

NeoGenomics Reports 9% Revenue Growth to $116 Million in the First Quarter

Read Now

Presented:

NeoGenomics Announces the Launch of Biomarker Assist KRAS Single Gene Testing (SGT) Program for Advanced or Metastatic (Stage IV) Non-Small Cell Lung Cancer Patients

Read Now

Presented:

NeoGenomics to Participate in the 20th Annual Needham Virtual Healthcare Conference

Read Now

Presented:

NeoGenomics Schedules its First Quarter 2021 Earnings Release for May 5, 2021

Read Now

Presented:

NeoGenomics Agrees to Acquire Trapelo Health

Read Now

Presented:

NeoGenomics and Elevation Oncology Announce Collaboration to Expand Genomic Testing for NRG1 Fusions Across Solid Tumors in Support of the Phase 2 CRESTONE Study

Read Now

Presented:

NeoGenomics To Participate In The Virtual Raymond James 42nd Annual Institutional Investors Conference

Read Now

Presented:

NeoGenomics To Participate In The Virtual 10th Annual SVB Leerink Global Healthcare Conference

Read Now

Presented:

NeoGenomics Reports 18% Revenue Growth to $126 Million in the Fourth Quarter

Read Now

Presented:

NeoGenomics Announces CEO Succession

Read Now